Pfizer Announces 6% Pneumococcal Vaccine Price Cut At Gavi Pledging Conference; Critics Say Reduction Not Enough

The Guardian: Vaccine price cut pledge not enough, critics tell Pfizer
“…At a donor conference in Berlin hosted by Angela Merkel to raise funds for the global vaccines alliance Gavi, Pfizer offered to cut the price [of its pneumococcal vaccine] from $3.30 a dose to $3.10. Each child needs three doses. The other company making the vaccine, the British drugmaker GlaxoSmithKline, said it would freeze the price for 10 years for middle-income countries that lose Gavi funding because of their increasing wealth…” (Boseley, 1/26).

Reuters: Pfizer cuts vaccine price for poor as Gavi group seeks $7.5 bln
“…Pfizer’s move comes as Gavi holds a major funding conference in Berlin at which it hopes to raise $7.5 billion from donors to pay for increased deployment of vaccines in the developing world between 2016 and 2020. The final amounted raised will be decided at the end of talks on Tuesday, although Gavi Chief Executive Seth Berkley said he was confident there would be enough money to immunize another 300 million children as planned…” (Hirschler, 1/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.